ICL Accelerating Biologicals Portfolio Growth in Brazil with Strategic Acquisition
Go back to ICL Accelerating Biologicals Portfolio Growth in Brazil with Strategic Acquisition| Vical, Inc. (NYSE: ICL) | Delayed: 5.42 -0.04 (0.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.46 | 52 Week High | $5.45 | |||
| Open | $5.40 | 52 Week Low | $3.52 | |||
| Day High | $5.44 | P/E | N/A | |||
| Day Low | $5.37 | EPS | $-0.92 | |||
| Volume | 593,151 | |||||
| Vical, Inc. (NYSE: ICL) | Delayed: 5.42 -0.04 (0.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.46 | 52 Week High | $5.45 | |||
| Open | $5.40 | 52 Week Low | $3.52 | |||
| Day High | $5.44 | P/E | N/A | |||
| Day Low | $5.37 | EPS | $-0.92 | |||
| Volume | 593,151 | |||||

